Avestar Capital LLC bought a new stake in KKR & Co. Inc. (NYSE:KKR – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,136 shares of the asset manager’s stock, valued at approximately $279,000.
A number of other hedge funds and other institutional investors have also modified their holdings of KKR. Canada Pension Plan Investment Board increased its position in shares of KKR & Co. Inc. by 198.6% in the second quarter. Canada Pension Plan Investment Board now owns 3,207,368 shares of the asset manager’s stock valued at $337,543,000 after acquiring an additional 2,133,290 shares during the last quarter. Bank of New York Mellon Corp increased its position in KKR & Co. Inc. by 64.7% during the second quarter. Bank of New York Mellon Corp now owns 4,036,821 shares of the asset manager’s stock worth $424,835,000 after buying an additional 1,585,447 shares during the last quarter. APG Asset Management N.V. acquired a new position in KKR & Co. Inc. during the second quarter worth approximately $154,468,000. Massachusetts Financial Services Co. MA increased its position in KKR & Co. Inc. by 6.4% during the second quarter. Massachusetts Financial Services Co. MA now owns 16,684,133 shares of the asset manager’s stock worth $1,755,838,000 after buying an additional 996,871 shares during the last quarter. Finally, Hsbc Holdings PLC increased its position in KKR & Co. Inc. by 315.6% during the second quarter. Hsbc Holdings PLC now owns 1,179,728 shares of the asset manager’s stock worth $124,623,000 after buying an additional 895,891 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.
Analysts Set New Price Targets
KKR has been the topic of a number of recent analyst reports. Argus raised KKR & Co. Inc. to a “strong-buy” rating in a research report on Thursday, August 1st. TD Cowen boosted their price target on KKR & Co. Inc. from $166.00 to $184.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. The Goldman Sachs Group upped their target price on KKR & Co. Inc. from $160.00 to $177.00 and gave the company a “buy” rating in a research report on Tuesday, November 19th. HSBC assumed coverage on KKR & Co. Inc. in a research report on Wednesday, September 18th. They issued a “buy” rating and a $148.00 target price on the stock. Finally, StockNews.com raised KKR & Co. Inc. to a “sell” rating in a research report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, KKR & Co. Inc. presently has a consensus rating of “Moderate Buy” and an average target price of $154.14.
Insider Transactions at KKR & Co. Inc.
In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This represents a 18.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The stock was bought at an average price of $11.13 per share, with a total value of $129,330,577.74. Following the completion of the acquisition, the insider now directly owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. This trade represents a 14.29 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Stock Down 0.7 %
NYSE KKR opened at $160.13 on Thursday. The business has a fifty day moving average price of $141.61 and a two-hundred day moving average price of $122.59. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. KKR & Co. Inc. has a fifty-two week low of $68.89 and a fifty-two week high of $162.73. The stock has a market capitalization of $142.23 billion, a PE ratio of 48.67, a PEG ratio of 1.26 and a beta of 1.61.
KKR & Co. Inc. (NYSE:KKR – Get Free Report) last released its earnings results on Thursday, October 24th. The asset manager reported $1.38 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.35. KKR & Co. Inc. had a return on equity of 5.77% and a net margin of 13.21%. The firm had revenue of $4.79 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period in the prior year, the company earned $0.73 earnings per share. Equities analysts expect that KKR & Co. Inc. will post 4.16 earnings per share for the current fiscal year.
KKR & Co. Inc. Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th were issued a dividend of $0.175 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.70 annualized dividend and a dividend yield of 0.44%. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 21.28%.
KKR & Co. Inc. Profile
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- How to Read Stock Charts for Beginners
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.